AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01694979 — intervention group
Intervention type: OTHER
Intervention: Moderate expiration effort
Description: Subjects perform a forced expiration at moderate effort
Study NCT01694979 — intervention group
Intervention type: OTHER
Intervention: Maximum expiration effort
Description: Subjects perform a forced expiration at maximum effort
Study NCT02786680 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: stroop test in condition DBS off
Description: Patients were evaluated in DBS Off
Study NCT02786680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stroop test in condition DBS on
Description: Patients were evaluated in DBS On
Study NCT00444977 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Case-management linkage intervention
Description: dental care
Study NCT00262990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EPO906 (Patupilone)
Study NCT00262990 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doxorubicin
Study NCT04108728 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: BRIEF SCORE AT INCLUSION
Description: BRIEF SCALE evaluation
Study NCT04108728 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: BRIEF SCORE AT INCLUSION
Description: BRIEF SCALE evaluation
Study NCT02699372 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02699372 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO6889450
Study NCT01124045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Difluprednate ophthalmic emulsion, 0.05%
Description: Topical ocular administration
Study NCT01124045 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone acetate ophthalmic suspension, 1.0%
Description: Topical ocular administration
Study NCT00730249 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methylphenidate hydrochloride
Description: sustained release, twice daily, dosage according to an individual titration schedule
Study NCT00730249 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: twice daily according to an individual titration schedule
Study NCT02411292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Description: Enrolled patients will receive real-time monitoring of peak and trough steady state anti-Xa levels. Out-of-range patients will receive real time dose adjustment of Enoxaparin using a clinical protocol developed with our inpatient pharmacists.
Study NCT02149927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Study NCT04308057 — intervention group
Intervention type: PROCEDURE
Intervention: Aquatic exercise
Description: Participants belonging to Group D (sedentary group) will be randomised 1-to-1 between remaining sedentary (n=20) and following a self-managed, 8-week, aquatic-based exercise programme (n=20). The latter group will be offered an 8-week access to pool facilities. For Group D participants, all baseline assessments will be repeated at 8 weeks.
Study NCT03629821 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ballet
Description: The classic ballet classes will respect biological limits of children. The sessions will be 75 minutes long, twice a week during 8 weeks. The class sequence will be: warm-up, follow by exercises about upper and lower limbs ballet positions and sequences of ballet jumps, and at the end a cool-down.
Study NCT01010906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaniprevir 300 mg
Description: single dose administration of 300 mg oral tablet
Study NCT03800771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cycléo BRAU
Description: Practice dual-task tests.
Study NCT01577927 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual home care
Description: Usual home care consists in supporting drug and oxygen therapy, mechanical ventilation, GP's assistance,and periodical in-hospital visit.
Study NCT01577927 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PT-assisted home rehabilitation
Description: Patient performs 50 min physical activity/working day autonomously by the help of a DVD. The physical activity consists in cyclette, calisthenic exercises, and training of the respiratory muscles.~Every two weeks, PT phones the patient for an educational reinforcement.
Study NCT03800771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GAITRITE®
Description: Routine practice dual-task tests.
Study NCT05640258 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: rotatory chair testing in a velocity step protocol.
Description: Tc was evaluated by the rotational velocity step test using the OtoaccessTM interface (Interacoustics Nydiag 200, Middlefart, Denmark). Subjects were seated on the rotatory chair wearing videonystagmography goggles with their heads supported and tilted 30° forward, thus bringing the horizontal semicircular canals plane perpendicular to the axis of rotation. Standard videonystagmography techniques were employed to record eye-movements. Subsequent to eye movements' calibration, the chair was accelerated about the yaw axis at 30°/sec2 to a maximal velocity of 90°/sec, followed by rotation at a constant velocity. After 57 seconds of constant velocity rotation, the chair was decelerated to zero velocity at 30°/sec2. The described velocity step was conducted both clockwise and counter-clockwise, giving a total run time of 4 minutes.
Study NCT01402622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol anesthesia
Description: In the TIVA and TIVA-P group, propofol and remifentanil were used for induction and maintenance of anaesthesia. In the control group, propofol and remifentanil were used for induction and anaesthesia was maintained with desflurane and remifentanil. In the control and TIVA-P group, ramosetron 0.3mg was administered at the end of surgery. In all patients, postoperative pain was controlled with fentanyl-based intravenous patient-controlled analgesia. he depth of anaesthesia was monitored with a bispectral index score monitor and maintained at 40-60.
Study NCT03732040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: miswak stick
Description: miswak stick use as preventive hygiene measures
Study NCT03732040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Miswak plus tooth brushing and tooth paste
Description: use of miswak stick with tooth brushing and fluoride toothpaste for oral hygiene measures
Study NCT03732040 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard preventive measures (tooth brushing , interdental cleaning and mouth rinse use containing CHX and Fluoride)
Description: use toothbrush with fluoride toothpaste and interdental cleaning by dental flossing and use mouth wash containing chlorohexadine
Study NCT00611351 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-thymocyte globulin
Study NCT00611351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: busulfan
Study NCT00611351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Study NCT00611351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mycophenolate mofetil
Study NCT00611351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tacrolimus
Study NCT00611351 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymerase chain reaction
Study NCT00611351 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymorphism analysis
Study NCT00611351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: flow cytometry
Study NCT00611351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Study NCT00611351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacogenomic studies
Study NCT00611351 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Study NCT00611351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic bone marrow transplantation
Study NCT00611351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: allogeneic hematopoietic stem cell transplantation
Study NCT00611351 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: peripheral blood stem cell transplantation
Study NCT01802242 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy
Description: Patients in this group will receive one of 2 treatment arms of their choice:~* Arm 1: VMAT delivery with integrated VMAT boost (IB-VMAT) GTV: 95Gy in 38fractions~* Arm 2: HDR-boost followed by VMAT GTV: 10Gy HDR + 76Gy in 38 fractions VMAT
Study NCT01802242 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No Active Treatment - completed Prior Radiation
Description: Already had prior radiation treatment. MRI-guided prostate biopsy at 3 years and PSA per standard practice
Study NCT01010906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vaniprevir 200 mg
Description: single dose administration of 200 mg oral tablet
Study NCT03928847 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Epigallocatechin-3-gallate (EGCG)
Description: Epigallocatechin-3-gallate (EGCG) capsules
Study NCT02173288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard medical therapy
Study NCT02173288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard medical therapy
Study NCT02173288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tolvaptan
Study NCT02173288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Study NCT02173288 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midodrine
Study NCT02173288 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midodrine
Study NCT01488084 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary Artery Bypass Graft Surgery
Description: Comparison of two techniques of saphenous vein graft harvesting for coronary artery bypass graft surgery
Study NCT01488084 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Graft Surgery
Description: Comparison of two techniques of saphenous vein graft harvesting for coronary artery bypass graft surgery
Study NCT01488084 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional open SVG harvesting
Description: SVG harvested using conventional open technique and manually distended with crystalloid solution
Study NCT03132636 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cemiplimab
Description: Regimen as per protocol
Study NCT02286622 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deflazacort
Description: Deflazacort, a glucocorticoid with anti-inflammatory and immunosuppressive effects, is used in treating a variety of diseases. Pharmacologically it is an inactive pro-drug which is metabolized immediately to the active metabolite 21-desacetyl-DFZ. The elimination of this metabolite is primarily via the urine in humans. Its potency is approximately 70 to 90% of prednisone and 6 mg of deflazacort has approximately the same anti-inflammatory potency as 5 mg of prednisolone or prednisone
Study NCT00983827 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aquatic treadmill training
Description: HydroWorx aquatic therapy pool with an underwater, integrated and adjustable speed treadmill
Study NCT03132155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 337
Description: 6-{(1R)-1-\[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)\[1,2,4\]triazolo\[4,3-a\]pyridin-3-yl\]ethyl}-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one•hydrate (1:1)
Study NCT03042091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene Glycol
Description: Given orally
Study NCT03042091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neomycin
Description: Given orally
Study NCT03042091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neomycin
Description: Given orally
Study NCT03042091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metronidazole Hydrochloride
Description: Given orally
Study NCT03042091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole Hydrochloride
Description: Given orally
Study NCT03042091 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic Conventional Surgery
Description: Undergo colorectal resection
Study NCT03042091 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Conventional Surgery
Description: Undergo colorectal resection
Study NCT00131495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone (transdermal patches)
Description: Testosterone patch (300mcg/day, changed twice a week for one year
Study NCT00131495 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo patch
Description: placebo patch changed twice a week for one year
Study NCT01442142 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CAAT: Appetite Awareness
Description: Participants in this Children's Appetite Awareness Training (CAAT) group learn to get in touch with the internal cues of hunger - aka the hunger meter - and practice skills to get back in touch with these internal cues of true hunger and fullness. Sessions occur once a week for 8 weeks.
Study NCT01442142 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CRST: Volcravo
Description: Participants in this Cue Reactivity and Sensitivity Training (CRST) group learn about how external cues can affect when and how much we eat (aka volcravo - the craving volcano). Over 8 weekly sessions, they practice skills to ride out the cravings external cues can cause.
Study NCT01142024 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glutathione
Description: NS 500ml + Glutathione 1.8g intravenously guttae 1-1.5ml/kg per hour,30 minutes before and during coronary angiography
Study NCT01142024 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline
Description: NS 500ml intravenously guttae 1-1.5ml/kg per hour,30 minutes before and during coronary angiography
Study NCT03974204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
Description: At the initial diagnostic assessment, 3mL of cerebrospinal fluid and 10 ml of blood sample will be collected in order to determine the proteomic profile. Cerebrospinal fluid will be collected during a lumbar puncture aiming to diagnose leptomeningeal metastases.
Study NCT03974204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid and blood sample collection if conclusions of initial diagnostic assessment are Lack of evidence according to EANO-ESMO classification
Description: 3mL of cerebrospinal fluid and 10 ml of blood sample will be collected:~* When suspected metastatic meningitis symptoms arise and~* at least 3 months after the initial diagnostic assessment, In order to determine the proteomic profile. Cerebrospinal fluid will be collected during a lumbar puncture aiming to diagnose leptomeningeal metastases.
Study NCT03974204 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid and blood sample collection if conclusions of initial diagnostic assessment are confirmed, probable or possible, leading to leptomeningeal metastase specific treatment
Description: 3mL of cerebrospinal fluid and 10 ml of blood sample will be collected:~* 1 month after the beginning of the specific treatment,~* 3 months after the beginning of the specific treatment. Cerebrospinal fluid will be collected during a lumbar puncture aiming to assess treatment response or at intrathecal injection of treatment.
Study NCT02698371 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: G1-Control: Futurabond®DC-SE (FBDC_SE)
Description: Futurabond®DC (FBDC) adhesive by self-etch (SE) mode bonding in NCCls restorations, was randomly assigned to premolar or molar teeth ensuring that this adhesive/mode is only apllied once in each participant.
Study NCT02698371 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: G2-Control: Futurabond®DC_SE_EE
Description: Futurabond®DC adhesive by self-etch mode with selective enamel etching (FBDC-SE-EE) bonding in NCCls restorations, was randomly assigned to premolar or molar teeth ensuring that this adhesive/mode is only apllied once in each participant.
Study NCT02698371 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: G3: Futurabond® U - ER (FBU_ER)
Description: FuturabondU® (FBU) adhesive by etch-and-rinse (ER) mode, bonding in NCCls restorations, was randomly assigned to premolar or molar teeth ensuring that this adhesive/mode is only apllied once in each participant.
Study NCT02698371 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: G4: Futurabond® U - SE (FBU_SE)
Description: FuturabondU® (FBU) adhesive by self-etch (SE) mode, bonding in NCCls restorations, was randomly assigned to premolar or molar teeth ensuring that this adhesive/mode is only apllied once in each participant.
Study NCT02698371 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: G5: Adhese® Universal - ER (ADU_ER)
Description: Adhese®Universal (ADU) adhesive by etch-and-rinse (ER) mode, bonding in NCCls restorations, was randomly assigned to premolar or molar teeth ensuring that this adhesive/mode is only apllied once in each participant.
Study NCT02698371 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: G6: Adhese® Universal - SE (ADU_SE)
Description: Adhese®Universal (ADU) adhesive by self-etch (SE) mode, bonding in NCCls restorations, was randomly assigned to premolar or molar teeth ensuring that this adhesive/mode is only apllied once in each participant.
Study NCT03139799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental - Puzzle Video Game Intervention
Description: The psychological intervention consists of two custom-made versions of popular commercial casual puzzle video games (Flow Free, Big Duck Games LCC; Bejeweled, PopCap Games). The puzzle games are delivered on tablet-computers computer (12.9-inch tablet computer iPad Pro, Apple Inc., Cupertino, CA, USA).
Study NCT03139799 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Experimental - Puzzle Video Game Intervention
Description: The psychological intervention consists of two custom-made versions of popular commercial casual puzzle video games (Flow Free, Big Duck Games LCC; Bejeweled, PopCap Games). The puzzle games are delivered on tablet-computers computer (12.9-inch tablet computer iPad Pro, Apple Inc., Cupertino, CA, USA).
Study NCT03139799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Control - Tablet Newspaper Reading Intervention
Description: The control intervention uses a newspaper/ magazine reading task that will be delivered to participants using the same device (iPad Pro) as in the experimental intervention. The newspaper/ magazine reading task will be running on the built-in Apple Newsstand application. Participants will be offered subscriptions for two newspapers and/or magazines that they are instructed to read following the same regime as in the experimental condition.
Study NCT03139799 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control - Tablet Newspaper Reading Intervention
Description: The control intervention uses a newspaper/ magazine reading task that will be delivered to participants using the same device (iPad Pro) as in the experimental intervention. The newspaper/ magazine reading task will be running on the built-in Apple Newsstand application. Participants will be offered subscriptions for two newspapers and/or magazines that they are instructed to read following the same regime as in the experimental condition.
Study NCT00267150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC-MPS)
Description: Experimental
Study NCT01442142 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined CAAT and CRST program
Description: Participants meet weekly for 14 weeks to learn about both Children's Appetite Awareness Training (CAAT) and Cue Reactivity and Sensitivity Training (CRST) - i.e. appetite awareness and external cues that affect food intake.
Study NCT04087824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI assisted recognition of colonic segments
Description: After receiving standard bowel preparation regimen, patients go through colonoscopy under the AI monitoring device. The whole withdrawal process is monitored by AI associated recognition system. Key colonic segments include ileocecal valve, ascending colon, transverse colon, descending colon, sigmoid colon and rectum. When typical anatomic sites are detected, the AI device will automatically captured relevant images and report the name of each segment on the screen. The operating endoscopy expert will give the final answer and judge the performance of AI, which is set as a golden standard. Then all the AI captured images will be reviewed by human group, which consists of three to five experienced endoscopic physicians.
Study NCT03928847 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epigallocatechin-3-gallate (EGCG)
Description: Epigallocatechin-3-gallate (EGCG) capsules